Literature DB >> 29562814

Efforts Toward Elimination of Infectious Agents in Blood Products.

Cyril Jacquot1,2,3,4, Meghan Delaney1,2,3,4.   

Abstract

The US blood supply has never been safer. This level of safety depends on a multifaceted approach including blood donor screening, sensitive infectious disease testing, and good manufacturing practice. However, risks remain for transfusion-transmitted infections due to bacterial contamination of platelets and emerging diseases. Thus, ongoing improvements in screening and testing are required. Newer pathogen reduction technologies have shown promise in further ameliorating the safety of the blood supply.

Entities:  

Keywords:  blood donor testing; blood supply safety; pathogen reduction technology; septic transfusion reaction; transfusion

Mesh：

Year:  2018        PMID： 29562814     DOI： 10.1177/0885066618756589

Source DB:  PubMed          Journal:  J Intensive Care Med        ISSN： 0885-0666            Impact factor:   3.510


  2 in total

1.  Proceedings of the Food and Drug Administration public workshop on pathogen reduction technologies for blood safety 2018 (Commentary, p. 3026).

Authors:  Chintamani Atreya; Simone Glynn; Michael Busch; Steve Kleinman; Edward Snyder; Sara Rutter; James AuBuchon; Willy Flegel; David Reeve; Dana Devine; Claudia Cohn; Brian Custer; Raymond Goodrich; Richard J Benjamin; Anna Razatos; Jose Cancelas; Stephen Wagner; Michelle Maclean; Monique Gelderman; Andrew Cap; Paul Ness
Journal:  Transfusion       Date:  2019-05-29       Impact factor: 3.157

2.  Non-ionizing 405 nm Light as a Potential Bactericidal Technology for Platelet Safety: Evaluation of in vitro Bacterial Inactivation and in vivo Platelet Recovery in Severe Combined Immunodeficient Mice.

Authors:  Michelle Maclean; Monique P Gelderman; Sandhya Kulkarni; Rachael M Tomb; Caitlin F Stewart; John G Anderson; Scott J MacGregor; Chintamani D Atreya
Journal:  Front Med (Lausanne)       Date:  2020-01-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.